Recent Selected Publications Supported by Schain Research
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT, Warnqvist A, Andersson TML, Leval A, Eklund M, Nordström T, Eloranta S, Schain F, Dearden L, Liwing J, Mehra M, Nair S, Pettersson A, Akre O, Aly M. Real world treatment utilization patterns in patients with castration-resistant prostate cancer. Scand J Urol. 2021 Jun 7:1-8. doi: 10.1080/21681805.2021.1936626. Epub ahead of print. PMID: 34096469.
Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape
Borgsten F, Gatopoulou X, Pisini M, Tambour M, Schain F, Jones C V, Ho Man Kwok K, Batyrbekova N, Björkholm M. European Journal of Haematology. March 2021
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain F, Batyrbekova N, Liwing J, Baculea S, Webb T, Remberger M, Mattsson J. Eur J Health Econ. March 2021
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Aly M, Leval A, Schain F, Liwing J, Lawson J, Vágó E, Nordström T, Andersson TM, Sjöland E, Wang C, Eloranta S, Akre O. Scand J Urol. 2020 Apr 4.
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Schain, F., Dominicus, A., Borgsten, F., Mozart, M., & Björkholm, M.
February 2020. Annals of Hematology, 99(2), 375–376.
Survival outcomes in myelofibrosis patients treated with ruxolitinib: a population-based cohort study in Sweden and Norway
Schain, F., Vago, E., Song, C., He, J., Liwing, J., Löfgren, C., & Björkholm, M.
December 2019. European Journal of Haematology, 103(6), 614–619.
Recent Selected Conference Abstracts Supported by Schain Research
Characteristics, Treatment Patterns and Predictors of Outcomes in Treatment-Naive Acute Myeloid Leukemia Patients Judged Ineligible for Intensive Chemotherapy in Sweden
Schain F, Gaudig M, Sandström K, Dominicus A, Jones CV, Björkholm M, Löfgren C. Clinical Lymphoma, Myeloma and Leukemia, Volume 21, S287. Published in issue: September 2021
Healthcare resource utilization and sickness absence in newly diagnosed multiple myeloma patients in Sweden: Trends in a changing treatment landscape
Borgsten, F., Gatopoulou, X., Pisini, M., Tambour, M., Schain, F., Jones, C., Ho Man Kwok, K., Hjortsberg, C., Björkholm, M. American Society of Hematology, 62nd ASH Annual Meeting and Exposition 5-8 december 2020.
Survival outcomes in patients with colorectal cancer in Sweden – A populationbased retrospective registry study
Pasquali, J., Schain, F., ISPOR Europe 16-19 November 2020.
Clinical outcomes and economic burden for bladder cancer patients: an analysis from a Swedish cancer registry
Bellmunt, J., Steinberg G., Powles, T., Fleming, S., Schain F., Batyrbekova, N., Henriksson, R., Ebrahim, F., Shalaby, W., Siefker-Radtke, A. J Clin Oncol 38: 2020 (suppl; abstr 5026).
Real-world treatment patterns in patients with castration-resistant prostate cancer
H.T. Vigneswaran., Warnqvist A., T.M.L Andersson, A., Leval, F., Schain, Liwing., J., S., Eloranta, A., Pettersson, O., Akre, M., Aly. J of Urology, 1 April, 2020, PD10-06.
Patient characterization and survival outcomes in pediatric chronic graft versus host disease patients: a population-based study in Sweden
Schain, F., Batyrbekova, N., Dominicus, A., Baculea, S., Remberger, M., Mattsson, J., & Toporski, J. The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706). Bone Marrow Transplant 55, 181–714, P204 (2020).